PRS
KYNB

Pinkerton Retirement Specialists’s Kyntra Bio KYNB Stock Holding History

Pinkerton Retirement Specialists’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed – – 253
2016
Q4 		$0 Hold
1
– – ﹤0.01% 621
2016
Q3 		$0 Hold
1
– – ﹤0.01% 627
2016
Q2 		$0 Buy
+1
New +$458 ﹤0.01% 617

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pinkerton Retirement Specialists's KYNB Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of Kyntra Bio (KYNB) in Q1 2017, closing a stake of 1 share.

Pinkerton Retirement Specialists first reported a position in KYNB in Q2 2016 and held it in 3 quarters. The position peaked at $0 in Q4 2016. 144 funds tracked by Wall St. Rank hold KYNB as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining Kyntra Bio position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 1 Kyntra Bio share in Q1 2017.
  • Pinkerton Retirement Specialists first reported a position in Kyntra Bio in Q2 2016 and held it in 3 quarters.
  • Pinkerton Retirement Specialists's Kyntra Bio position peaked at $0 in Q4 2016.
  • 144 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.